
- Volume 0 0
PHARMACISTS URGED TO CURB TAMIFLU STOCKPILING ACTIVITIES
Leaders of the profession called on thenation's pharmacists to discourage consumersfrom stockpiling supplies ofTamiflu—a practice they said may createa serious threat of shortages during thecoming influenza season.
Reports that consumers are hoardingquantities of the drug in anticipation of apossible outbreak of avian flu make itimportant for pharmacists and physicians"to address the problem to helpassure that the correct medication isavailable at the right time," the AmericanPharmacists Association (APhA) said.
"Stockpiling to protect against an as-yet-undefined threat creates its ownreal danger—that the antiviral productswill not be available to mitigate the realthreat of this season's influenza," APhAtold pharmacists.For its part, the associationurged itsmembers to "have acontingency plan toaccess appropriate quantities of medications,vaccines, and supplies to servepatients or be prepared to referpatients to other sources."
In addition to the possibility thatTamiflu hoarding may create shortagesduring the coming months, the APhAsaid there are other dangers associatedwith stockpiling the drug. "Indiscriminateor casual use of antivirals or antibioticscan create drug-resistant strains" thatmay eventually render these treatmentsuseless, an official from the associationreminded pharmacists.
Articles in this issue
almost 20 years ago
Resealable and Nultraviolet Ultraviolet (UV) Inhibitant Bagsalmost 20 years ago
High Alert Insulin Binalmost 20 years ago
Hydase (hyaluronidase injection, USP)almost 20 years ago
Humira (adalimumab)almost 20 years ago
INVANZ (ertapenem for injection)almost 20 years ago
Compounding HOTLINEalmost 20 years ago
Customer Guilty of Prescription Fraud by Supporting Friendalmost 20 years ago
Counterfeit Drugs: A Life-or-Death Problemalmost 20 years ago
Qui Tam Lawsuits Blow the Whistle on PBMsalmost 20 years ago
Can You Read These Rxs?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.